Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recognition of viral nucleic acids by multiple pattern-recognition receptors converges on TANK-binding kinase 1 (TBK1) to initiate type I interferon responses and antiviral immunity. While this canonical role is well established, recent studies using genetic ablation and pharmacological inhibition have reframed TBK1 as a context-dependent regulator of both innate and adaptive immunity across distinct cell lineages. Here, we review emerging cell-type-specific functions of TBK1 that extend beyond classical interferon signaling, repositioning it as a central coordinator of immune cell survival, differentiation, and effector function. We further discuss how pathways that signal through TBK1 may, thus, contribute to vaccine adjuvanticity, emphasizing this kinase as a potential target for vaccine-induced immunity. Finally, we outline how TBK1-dependent pathways may be harnessed for the design of next-generation vaccines.

More information Original publication

DOI

10.1016/j.coviro.2026.101545

Type

Journal article

Publication Date

2026-04-28T00:00:00+00:00

Volume

76